Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poornews2021-10-09T15:06:57+00:00October 9th, 2021|The New York Times|
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shotnews2021-10-04T17:16:18+00:00October 4th, 2021|The New York Times|
Pressure Grows on U.S. Companies to Share Covid Vaccine Technologynews2021-09-22T19:23:27+00:00September 22nd, 2021|The New York Times|
¿La vacuna Johnson & Johnson requerirá refuerzo?news2021-08-20T23:50:24+00:00August 20th, 2021|The New York Times|
What to Know About Boosters if You Got the Johnson & Johnson Vaccinenews2021-08-19T00:52:34+00:00August 19th, 2021|The New York Times|
F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Monthnews2021-08-04T08:25:24+00:00August 4th, 2021|The New York Times|
Some Are Chasing Extra Vaccine Shots, While Scientists Debatenews2021-07-30T08:57:08+00:00July 30th, 2021|The New York Times|
Vaccine Makers Are Asked to Expand Safety Studies on Childrennews2021-07-26T23:27:07+00:00July 26th, 2021|The New York Times|
Johnson & Johnson podría ser menos eficaz contra la variante deltanews2021-07-24T13:00:07+00:00July 24th, 2021|The New York Times|
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggestsnews2021-07-20T21:20:49+00:00July 20th, 2021|The New York Times|
